Susceptibility of chromosomes from patients with Down's syndrome to 7,12-dimethylbenz(a) anthracene-induced aberrations in vitro.
D000293:Adolescent; D000328:Adult; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D002273:Carcinogens / Q000494:pharmacology*; D002842:Chromatids / Q000187:drug effects / Q000528:radiation effects; D002869:Chromosome Aberrations / Q000528:radiation effects; D004247:DNA / Q000096:biosynthesis*; D004260:DNA Repair; D004261:DNA Replication / Q000187:drug effects* / Q000528:radiation effects; D004314:Down Syndrome; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000528:radiation effects; D011804:Quinolines / Q000494:pharmacology; D013936:Thymidine / Q000096:biosynthesis; D014314:Trisomy; D014316:Tritium; D014466:Ultraviolet Rays
D001551:Benz(a)Anthracenes; D002273:Carcinogens; D011804:Quinolines; D014316:Tritium; D004247:DNA; D013936:Thymidine